Web Stats Provided By Google Analytics

The Raw Stem Cell News Feed

The Stem Cell Research Newswire: Comprehensive Real-Time News Feed for Stem Cell Research

Monday, March 17, 2014

Fate Therapeutics Reports Fourth Quarter and Full Year 2013 Financial Results

Fate Therapeutics, Inc. , a biopharmaceutical company engaged in the discovery and development of adult stem cell modulators to treat orphan diseases, today reported therapeutic program updates and announced financial results for the fourth quarter and year ended December 31, 2013.

http://ift.tt/PJrtWc

No comments:

Post a Comment

Popular Stem Cell Roundup Posts